NIH Research Festival 2012 Program - Research Festival - National ...

Poster Session III
Natcher Conference Center
ENDOC:
Endocrine/Diabetes/Metabolism
56
Thursday, October 11, 2012
10:00 a.m.–Noon
ENDOC-1 KS Awad, S Wang, RL Danner (CC)*
Peroxisome Proliferator-activated Receptor (PPAR) gamma and
G-protein Coupled Receptor 40 (GPCR40) Function as an Integrated
Two-receptor Signaling Pathway
ENDOC-2 SA Beall, K Moon, E Widra, A DeCherney, F Chang (NICHD)
Matched samples comparison of in vitro fertilization (IVF) clinical
outcomes associated with Leuprolide Acetate (LA) versus human
Chorionic Gonadotropin (hCG) trigger for oocyte maturation
ENDOC-3 T Cai, H Hirai, A Notkins (NIDCR)
Elucidation of the Transcriptional Regulation of the Dense Core Vesicle
Protein IA-2: CREB and CREB-Related Binding Sites
ENDOC-4 CS Cheung, JC Lui, J Baron (NIDCD)*
Identification of peptides that bind growth plate chondrocytes
by phage display: a first step toward targeted therapy.
ENDOC-5 KM Devine, AY Armstrong, JH Segars, M Merino, M Linehan,
A Venkatesan (NICHD)
T2-weighted Signal Intensity Correlates with Histology in Patients with
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
ENDOC-6 AE Hanish, JA Butman, AE Huey, MD Lee, E Yin, LA Hunter,
MD Hicks, T Singh, M Tsang, JC Han (NICHD)
Pineal hypoplasia and decreased melatonin in patients with PAX6
haploinsufficiency due to WAGR syndrome or PAX6 mutations
ENDOC-7 MJ Hill, KS Richter, G Levy, AH DeCherney, ED Levens, G Suthar,
E Widra, MJ Levy (NICHD)
Elevated progesterone on the day of hCG administration negatively affects
clinical pregnancy in both cleavage and blastocyst embryo transfers.
ENDOC-8 S Jain, IR Azua, M White, JM Guettier, J Wess (NIDDK)*
Selective activation of Gq signaling in pancreatic beta cells in vivo improves
beta cell function and whole body glucose homeostasis
ENDOC-9 T Jourdan, G Godlewski, R Cinar, J Tam, G Szanda, A Bertola, J Liu,
T Han, B Mukhopadhyay, C Ju, G Kunos (NIAAA)*
Peripheral cannabinoid CB1 receptor (CB1R) blockade reverses β-cell loss,
hyperglycemia by reversing macrophage-induced activation of the NLRP3
inflammasome in a rat model of type 2 diabetes (T2DM).
*FARE Award Winner